Antibody Responses to Natural SARS-CoV-2 Infection or after COVID-19 Vaccination

The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the causative agent of the ongoing pandemic of coronavirus disease 2019 (COVID-19). The clinical severity of COVID-19 ranges from asymptomatic to critical disease and, eventually, death in smaller subsets of pati...

Descripción completa

Detalles Bibliográficos
Autor principal: Altawalah, Haya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402626/
https://www.ncbi.nlm.nih.gov/pubmed/34452035
http://dx.doi.org/10.3390/vaccines9080910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402626/
https://www.ncbi.nlm.nih.gov/pubmed/34452035
http://dx.doi.org/10.3390/vaccines9080910

Ejemplares similares